The Department of Medical Oncology and Therapeutics Research sponsors a large number of therapeutic clinical trials for solid tumor malignancies. These include:
- Phase III trials, which are large comparative studies that most frequently assess survival and progression-free survival
- Phase II trials, which are smaller studies early in the development of a drug or regimen that typically focus on response and toxicity data
- Phase I trials, where the primary aim is to determine the types of toxicities and maximum tolerated dose (MTD) of a new agent
View our searchable Clinical Trials Online database for more information.
The Department of Medical Oncology and Therapeutics Research is also affiliated with the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Southwest Oncology Group (SWOG) and the Radiation Therapy Oncology Group (RTOG).
For information about enrolling in a clinical trial, contact our New Patient Services department at 800-826-HOPE (4673).